Pub Date : 2026-01-04DOI: 10.1016/j.yjmcc.2025.12.012
C.E.R. Smith, C.J. Quinn, J.D. Clarke, Z. Sultan, H. Najem, N.C. Denham, D.C. Hutchings, A.S. Whitley, G.W.P. Madders, J.L. Caldwell, L.K. Toms, D.A. Eisner, C. Pinali, A.W. Trafford, K.M. Dibb
Transverse (t)-tubules ensure a uniform rise in cellular Ca2+ facilitating cardiac contraction. They play a key role in the large mammalian atria (including human) and their loss in heart failure is associated with impaired Ca2+ release. While t-tubule restoration is therefore an ideal therapeutic target, atrial t-tubule development is not well understood. Here we sought to determine how atrial t-tubules develop and the impact on Ca2+ handling. Atrial postnatal development was examined in sheep from newborn through to adulthood. T-tubule development was assessed using confocal microscopy and serial block face Scanning Electron Microscopy. Voltage clamp coupled with Ca2+ epifluorescence was used to assess concomitant functional changes to Ca2+ handling. Atrial t-tubule density increased until 3 months of age when the t-tubule network was disordered. As development continued t-tubules became more ordered but surprisingly the distance of the cell interior to t-tubule membrane increased due to a lack of additional t-tubules coupled with increased cell width. As t-tubules developed, L-type Ca2+ current density (ICa-L) and sarcoplasmic reticulum (SR) Ca2+ content decreased. Although these changes would be expected to decrease Ca2+ transient amplitude, Ca2+ buffering was simultaneously reduced which our data suggests maintains Ca2+ transient amplitude during neonatal development. By understanding how the Ca2+ transient is preserved despite drastic changes in t-tubule density and structure during development, this study may provide insights into adaptive mechanisms in Ca2+ cycling that mitigate the impact of reduced t-tubule density.
{"title":"Atrial t-tubules adopt a distinct developmental state as Ca2+ handling matures postnatally","authors":"C.E.R. Smith, C.J. Quinn, J.D. Clarke, Z. Sultan, H. Najem, N.C. Denham, D.C. Hutchings, A.S. Whitley, G.W.P. Madders, J.L. Caldwell, L.K. Toms, D.A. Eisner, C. Pinali, A.W. Trafford, K.M. Dibb","doi":"10.1016/j.yjmcc.2025.12.012","DOIUrl":"10.1016/j.yjmcc.2025.12.012","url":null,"abstract":"<div><div>Transverse (t)-tubules ensure a uniform rise in cellular Ca<sup>2+</sup> facilitating cardiac contraction. They play a key role in the large mammalian atria (including human) and their loss in heart failure is associated with impaired Ca<sup>2+</sup> release. While t-tubule restoration is therefore an ideal therapeutic target, atrial t-tubule development is not well understood. Here we sought to determine how atrial t-tubules develop and the impact on Ca<sup>2+</sup> handling. Atrial postnatal development was examined in sheep from newborn through to adulthood. T-tubule development was assessed using confocal microscopy and serial block face Scanning Electron Microscopy. Voltage clamp coupled with Ca<sup>2+</sup> epifluorescence was used to assess concomitant functional changes to Ca<sup>2+</sup> handling. Atrial t-tubule density increased until 3 months of age when the t-tubule network was disordered. As development continued t-tubules became more ordered but surprisingly the distance of the cell interior to t-tubule membrane increased due to a lack of additional t-tubules coupled with increased cell width. As t-tubules developed, L-type Ca<sup>2+</sup> current density (<em>I</em><sub>Ca-L</sub>) and sarcoplasmic reticulum (SR) Ca<sup>2+</sup> content decreased. Although these changes would be expected to decrease Ca<sup>2+</sup> transient amplitude, Ca<sup>2+</sup> buffering was simultaneously reduced which our data suggests maintains Ca<sup>2+</sup> transient amplitude during neonatal development. By understanding how the Ca<sup>2+</sup> transient is preserved despite drastic changes in t-tubule density and structure during development, this study may provide insights into adaptive mechanisms in Ca<sup>2+</sup> cycling that mitigate the impact of reduced t-tubule density.</div></div>","PeriodicalId":16402,"journal":{"name":"Journal of molecular and cellular cardiology","volume":"212 ","pages":"Pages 60-74"},"PeriodicalIF":4.7,"publicationDate":"2026-01-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145911832","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-02DOI: 10.1016/j.yjmcc.2025.12.010
Sophia A. Eikenberry, Michelle L. Gumz
Circadian rhythms drive cardiovascular health, and when dysfunctional, disease. Circadian biology rules daily rhythms in physiological mechanisms which allow our bodies to coordinate function with the demands of the external environment. However, the machinery underlying circadian rhythms, termed the “molecular clock”, can become altered by both external and internal factors. For instance, breaking the clock through disrupted light exposure can drive high blood pressure, which is detrimental to cardiovascular health. Importantly, cardiovascular disease itself can disrupt the molecular clock, further exacerbating pathology. The focus of this review is this latter aspect of the bi-directional relationship between circadian machinery and cardiovascular function, investigated in preclinical models. First, we describe the importance of blood pressure regulation and relevant systems. We then describe the existence of circadian rhythms in blood pressure, and briefly, how a broken clock can disrupt these rhythms and lead to disease. The focus of this review will be to outline evidence from pre-clinical and translational studies investigating the direct impact of cardiovascular disease on circadian machinery in the brain, heart, aorta, and kidney. This is with the goal of 1) highlighting the potential for harnessing the molecular clock through circadian interventions in combination with other treatment, and 2) aiding pre-clinical cardiovascular researchers in understanding their results which may be impacted by time of day.
{"title":"Watching the clock: Blood pressure and cardiovascular disease influence circadian machinery in pre-clinical models","authors":"Sophia A. Eikenberry, Michelle L. Gumz","doi":"10.1016/j.yjmcc.2025.12.010","DOIUrl":"10.1016/j.yjmcc.2025.12.010","url":null,"abstract":"<div><div>Circadian rhythms drive cardiovascular health, and when dysfunctional, disease. Circadian biology rules daily rhythms in physiological mechanisms which allow our bodies to coordinate function with the demands of the external environment. However, the machinery underlying circadian rhythms, termed the “molecular clock”, can become altered by both external and internal factors. For instance, breaking the clock through disrupted light exposure can drive high blood pressure, which is detrimental to cardiovascular health. Importantly, cardiovascular disease itself can disrupt the molecular clock, further exacerbating pathology. The focus of this review is this latter aspect of the bi-directional relationship between circadian machinery and cardiovascular function, investigated in preclinical models. First, we describe the importance of blood pressure regulation and relevant systems. We then describe the existence of circadian rhythms in blood pressure, and briefly, how a broken clock can disrupt these rhythms and lead to disease. The focus of this review will be to outline evidence from pre-clinical and translational studies investigating the direct impact of cardiovascular disease on circadian machinery in the brain, heart, aorta, and kidney. This is with the goal of 1) highlighting the potential for harnessing the molecular clock through circadian interventions in combination with other treatment, and 2) aiding pre-clinical cardiovascular researchers in understanding their results which may be impacted by time of day.</div></div>","PeriodicalId":16402,"journal":{"name":"Journal of molecular and cellular cardiology","volume":"212 ","pages":"Pages 51-59"},"PeriodicalIF":4.7,"publicationDate":"2026-01-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145900581","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-24DOI: 10.1016/j.yjmcc.2025.12.011
Austin Angelotti , Thiruvelselvan Ponnusamy , Vinay Kumar , Gianna V. Passarelli , Jozef Malysz , Balakrishnan Mahesh , Behzad Soleimani , Elisa A. Bradley , Shyam S. Bansal
Background
Dilated cardiomyopathy (DCM) is characterized by increased infiltration and activation of the innate immune system, including neutrophils, monocytes/macrophages, and dendritic cells. However, the phenotypic profile of cardiac CD3+ T-cells and its CD4+ and CD8+ subsets have not been characterized in DCM patients.
Methods
We studied phenotypic signatures of T-cell subsets by analyzing publicly available single-cell and single-nuclear transcriptomic datasets from control and failing hearts of DCM patients.
Results
Our analysis revealed increased cardiac infiltration of CD3+ T-cells in DCM patients with transcriptomic signatures indicating antigenic activation, T-cell exhaustion, diminished oxidative phosphorylation, and elevated TNF/NFκB and profibrotic TGF signaling. Among T-cell subsets, both CD4+ and CD8+ T-cells were found to be highly proliferative (increased G2M) and activated. Transcription profiling demonstrated four phenotypically different subsets for both CD8+ and CD4+ T-cells, however, only CD4+ T-cell subsets, regulatory T-cells and tissue resident memory (TRM) CD4+ T-cells, were significantly increased. Importantly, TRM cells displayed decreased expression of classical egress markers, such as CCR7, SELL, and MAL, and increased pro-inflammatory and pro-fibrotic signaling. We also observed increased estrogen receptor (ER)α expressing (with amplified ERα signaling) cardiac CD4+ T-cells which directly correlated with systolic dysfunction and mediated their pro-fibrotic effects in DCM patients.
Conclusion
Here we demonstrate for the first time, an “activated phenotype” with increased pro-inflammatory and profibrotic signaling in cardiac CD3+ T-cells and its CD4+ helper T-cell subset in DCM hearts. Notably, increased ERα signaling provide novel avenues for targeted immunomodulatory therapies to modify DCM progression.
{"title":"Phenotypes and mechanisms of dysfunctional cardiac T-lymphocytes in dilated cardiomyopathy patients","authors":"Austin Angelotti , Thiruvelselvan Ponnusamy , Vinay Kumar , Gianna V. Passarelli , Jozef Malysz , Balakrishnan Mahesh , Behzad Soleimani , Elisa A. Bradley , Shyam S. Bansal","doi":"10.1016/j.yjmcc.2025.12.011","DOIUrl":"10.1016/j.yjmcc.2025.12.011","url":null,"abstract":"<div><h3>Background</h3><div>Dilated cardiomyopathy (DCM) is characterized by increased infiltration and activation of the innate immune system, including neutrophils, monocytes/macrophages, and dendritic cells. However, the phenotypic profile of cardiac CD3<sup>+</sup> T-cells and its CD4<sup>+</sup> and CD8<sup>+</sup> subsets have not been characterized in DCM patients.</div></div><div><h3>Methods</h3><div>We studied phenotypic signatures of T-cell subsets by analyzing publicly available single-cell and single-nuclear transcriptomic datasets from control and failing hearts of DCM patients.</div></div><div><h3>Results</h3><div>Our analysis revealed increased cardiac infiltration of CD3<sup>+</sup> T-cells in DCM patients with transcriptomic signatures indicating antigenic activation, T-cell exhaustion, diminished oxidative phosphorylation, and elevated TNF/NFκB and profibrotic TGF signaling. Among T-cell subsets, both CD4<sup>+</sup> and CD8<sup>+</sup> T-cells were found to be highly proliferative (increased G2M) and activated. Transcription profiling demonstrated four phenotypically different subsets for both CD8<sup>+</sup> and CD4<sup>+</sup> T-cells, however, only CD4<sup>+</sup> T-cell subsets, regulatory T-cells and tissue resident memory (TRM) CD4<sup>+</sup> T-cells, were significantly increased. Importantly, TRM cells displayed decreased expression of classical egress markers, such as CCR7, SELL, and MAL, and increased pro-inflammatory and pro-fibrotic signaling. We also observed increased estrogen receptor (ER)α expressing (with amplified ERα signaling) cardiac CD4<sup>+</sup> T-cells which directly correlated with systolic dysfunction and mediated their pro-fibrotic effects in DCM patients.</div></div><div><h3>Conclusion</h3><div>Here we demonstrate for the first time, an “activated phenotype” with increased pro-inflammatory and profibrotic signaling in cardiac CD3<sup>+</sup> T-cells and its CD4<sup>+</sup> helper T-cell subset in DCM hearts. Notably, increased ERα signaling provide novel avenues for targeted immunomodulatory therapies to modify DCM progression.</div></div>","PeriodicalId":16402,"journal":{"name":"Journal of molecular and cellular cardiology","volume":"212 ","pages":"Pages 16-25"},"PeriodicalIF":4.7,"publicationDate":"2025-12-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145843987","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-22DOI: 10.1016/j.yjmcc.2025.12.008
Kripa Chitre , Olga E. Karpicheva , Chloe J. King , Michael J. Rynkiewicz , Axel J. Fenwick , John F. Dawson , D. Brian Foster , William Lehman , Anthony Cammarato
Electrostatic interactions between actin residues K326 and K328 and tropomyosin bias tropomyosin to an F-actin location where it blocks myosin attachment. K326/328 acetylation neutralizes their charge, potentially disrupting thin filament-based contractile regulation. We verified acetylation of K326/328 on human cardiac actin (ACTC1) and generated recombinant K326/328Q, pseudo-acetylated ACTC1. Pseudo-acetylation reduced inhibition of myosin-driven motility of F-actin-tropomyosin and F-actin-tropomyosin-troponin at low Ca2+. Cryo-EM-based and computational modeling revealed that pseudo-acetylation did not alter tropomyosin positioning along F-actin but decreased local F-actin-tropomyosin interaction energy. Thus, by reducing the energetic demands required for myosin to displace tropomyosin, ACTC1 K326/328 acetylation may promote contractile activation.
{"title":"Pseudo-acetylation of ACTC1 K326 and K328 promotes dysinhibition of reconstituted human cardiac thin filaments","authors":"Kripa Chitre , Olga E. Karpicheva , Chloe J. King , Michael J. Rynkiewicz , Axel J. Fenwick , John F. Dawson , D. Brian Foster , William Lehman , Anthony Cammarato","doi":"10.1016/j.yjmcc.2025.12.008","DOIUrl":"10.1016/j.yjmcc.2025.12.008","url":null,"abstract":"<div><div>Electrostatic interactions between actin residues K326 and K328 and tropomyosin bias tropomyosin to an F-actin location where it blocks myosin attachment. K326/328 acetylation neutralizes their charge, potentially disrupting thin filament-based contractile regulation. We verified acetylation of K326/328 on human cardiac actin (ACTC1) and generated recombinant K326/328Q, pseudo-acetylated ACTC1. Pseudo-acetylation reduced inhibition of myosin-driven motility of F-actin-tropomyosin and F-actin-tropomyosin-troponin at low Ca<sup>2+</sup>. Cryo-EM-based and computational modeling revealed that pseudo-acetylation did not alter tropomyosin positioning along F-actin but decreased local F-actin-tropomyosin interaction energy. Thus, by reducing the energetic demands required for myosin to displace tropomyosin, ACTC1 K326/328 acetylation may promote contractile activation.</div></div>","PeriodicalId":16402,"journal":{"name":"Journal of molecular and cellular cardiology","volume":"212 ","pages":"Pages 10-15"},"PeriodicalIF":4.7,"publicationDate":"2025-12-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145827921","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-21DOI: 10.1016/j.yjmcc.2025.12.007
Dogacan Yücel , Calvin Smith , Natalia Ferreira de Araujo , Fernando Souza-Neto , Upendra Chalise , Grace Schuler , Bayardo I. Garay , Jennifer L. Mikkila , Omar Atef Abdelhamid Mahmoud , Pratima Mandal , Verena Höffken , Joachim Kremerskothen , Rita C.R. Perlingeiro , Jop H. van Berlo
{"title":"Corrigendum to ‘Small-scale siRNA screen reveals WWC2 as a novel regulator of cardiomyocyte mitosis’ [Journal of Molecular and Cellular Cardiology 210 (2025) 127–136]","authors":"Dogacan Yücel , Calvin Smith , Natalia Ferreira de Araujo , Fernando Souza-Neto , Upendra Chalise , Grace Schuler , Bayardo I. Garay , Jennifer L. Mikkila , Omar Atef Abdelhamid Mahmoud , Pratima Mandal , Verena Höffken , Joachim Kremerskothen , Rita C.R. Perlingeiro , Jop H. van Berlo","doi":"10.1016/j.yjmcc.2025.12.007","DOIUrl":"10.1016/j.yjmcc.2025.12.007","url":null,"abstract":"","PeriodicalId":16402,"journal":{"name":"Journal of molecular and cellular cardiology","volume":"211 ","pages":"Page 131"},"PeriodicalIF":4.7,"publicationDate":"2025-12-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145810350","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-20DOI: 10.1016/j.yjmcc.2025.12.009
Haoqi Li , Huimin Li , Yufan Chao , Yaozhao Li , Zijie Cheng , Yuqing Li , Yun Yin , Tao Chen , Xin Dong , Dan Wu , Qingxun Hu
Redox homeostasis is crucial for cellular function and signaling, with its disruption linked to various diseases. Given the compartment-specific nature of redox regulation, we employed highly responsive genetically encoded fluorescent sensors, including Hyper7, iNap, and roGFP2, to achieve real-time in situ tracking of the redox dynamics of H2O2, NADPH and GSH in the cytoplasm and mitochondria. It revealed that glycolysis and oxidative phosphorylation differentially modulate redox metabolites across subcellular domains, demonstrating metabolic pathway-specific regulation of redox equilibrium. Pathological modeling (cardiac hypertrophy, ischemia-reperfusion and cuproptosis) characterized mitochondrial redox systems exhibit superior stress-responsive regulation versus cytoplasmic counterparts, displaying enhanced dynamic responses during injury progression. These results suggest that precise subcellular redox mapping delivers critical insights into dynamic signal transduction mechanisms and proposes targeted therapeutic avenues for redox-associated pathologies through compartment-specific interventions.
{"title":"Biosensors reveal subcellular redox status in live cells","authors":"Haoqi Li , Huimin Li , Yufan Chao , Yaozhao Li , Zijie Cheng , Yuqing Li , Yun Yin , Tao Chen , Xin Dong , Dan Wu , Qingxun Hu","doi":"10.1016/j.yjmcc.2025.12.009","DOIUrl":"10.1016/j.yjmcc.2025.12.009","url":null,"abstract":"<div><div>Redox homeostasis is crucial for cellular function and signaling, with its disruption linked to various diseases. Given the compartment-specific nature of redox regulation, we employed highly responsive genetically encoded fluorescent sensors, including Hyper7, iNap, and roGFP2, to achieve real-time in situ tracking of the redox dynamics of H<sub>2</sub>O<sub>2</sub>, NADPH and GSH in the cytoplasm and mitochondria. It revealed that glycolysis and oxidative phosphorylation differentially modulate redox metabolites across subcellular domains, demonstrating metabolic pathway-specific regulation of redox equilibrium. Pathological modeling (cardiac hypertrophy, ischemia-reperfusion and cuproptosis) characterized mitochondrial redox systems exhibit superior stress-responsive regulation versus cytoplasmic counterparts, displaying enhanced dynamic responses during injury progression. These results suggest that precise subcellular redox mapping delivers critical insights into dynamic signal transduction mechanisms and proposes targeted therapeutic avenues for redox-associated pathologies through compartment-specific interventions.</div></div>","PeriodicalId":16402,"journal":{"name":"Journal of molecular and cellular cardiology","volume":"212 ","pages":"Pages 1-9"},"PeriodicalIF":4.7,"publicationDate":"2025-12-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145802285","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-19DOI: 10.1016/j.yjmcc.2025.12.005
Yang Zhou , Xiao-Ping Xie , Bo-Lai Shen , Ao Wang , Bo-Wen Li , Zhi-Wei Wang
Background
Aortic dissection (AD) is a life-threatening cardiovascular condition characterized by high morbidity and mortality rates. However, the molecular mechanism of intracellular pH in AD development has not been fully elucidated. In this study, the role of carbonic anhydrase 9 (CA9) in VSMCs intracellular pH and the regulatory mechanism were investigated.
Methods
Cell viability was examined by cell counting kit-8 (CCK-8) and intracellular pH was detected by BCECF-AM probe. The regulation of CA9 transcription by HIF-1α was measured by Cut &run-qPCR assay. The levels of CA9, HIF-1α, MMP2 and α-SMA were evaluated by RT-qPCR, Western blot and Immunofluorescence.
Results
Our results demonstrated that CA9 was significantly upregulated in AD tissues, primarily localized in VSMCs, and associated with increased MMP2 levels, while α-SMA levels decreased. Silencing CA9 in VSMCs resulted in reduced cell viability and increased intracellular pH. Additionally, we found that HIF-1α was upregulated in AD, regulating CA9 expression in VSMCs. Treatment with JTC801 in a BAPN-induced mouse model reduced CA9 and HIF-1α expression, improving survival and decreasing AD incidence.
Conclusion
This study establishes CA9 as a hypoxia-responsive mediator of pH dysregulation in AD, modulated by HIF-1α. Targeting the HIF-1α/CA9 axis with JTC801 presents a novel therapeutic strategy to restore VSMC homeostasis and ECM integrity. These findings advance our understanding of intracellular pH in AD and highlight this approach may be a potential therapeutic target.
{"title":"JTC801 inhibited CA9 activation via HIF-1α to promotes alkaliptosis in vascular smooth muscle cells and alleviate the formation of aortic dissection","authors":"Yang Zhou , Xiao-Ping Xie , Bo-Lai Shen , Ao Wang , Bo-Wen Li , Zhi-Wei Wang","doi":"10.1016/j.yjmcc.2025.12.005","DOIUrl":"10.1016/j.yjmcc.2025.12.005","url":null,"abstract":"<div><h3>Background</h3><div>Aortic dissection (AD) is a life-threatening cardiovascular condition characterized by high morbidity and mortality rates. However, the molecular mechanism of intracellular pH in AD development has not been fully elucidated. In this study, the role of carbonic anhydrase 9 (CA9) in VSMCs intracellular pH and the regulatory mechanism were investigated.</div></div><div><h3>Methods</h3><div>Cell viability was examined by cell counting kit-8 (CCK-8) and intracellular pH was detected by BCECF-AM probe. The regulation of CA9 transcription by HIF-1α was measured by Cut &run-qPCR assay. The levels of CA9, HIF-1α, MMP2 and α-SMA were evaluated by RT-qPCR, Western blot and Immunofluorescence.</div></div><div><h3>Results</h3><div>Our results demonstrated that CA9 was significantly upregulated in AD tissues, primarily localized in VSMCs, and associated with increased MMP2 levels, while α-SMA levels decreased. Silencing CA9 in VSMCs resulted in reduced cell viability and increased intracellular pH. Additionally, we found that HIF-1α was upregulated in AD, regulating CA9 expression in VSMCs. Treatment with JTC801 in a BAPN-induced mouse model reduced CA9 and HIF-1α expression, improving survival and decreasing AD incidence.</div></div><div><h3>Conclusion</h3><div>This study establishes CA9 as a hypoxia-responsive mediator of pH dysregulation in AD, modulated by HIF-1α. Targeting the HIF-1α/CA9 axis with JTC801 presents a novel therapeutic strategy to restore VSMC homeostasis and ECM integrity. These findings advance our understanding of intracellular pH in AD and highlight this approach may be a potential therapeutic target.</div></div>","PeriodicalId":16402,"journal":{"name":"Journal of molecular and cellular cardiology","volume":"212 ","pages":"Pages 75-88"},"PeriodicalIF":4.7,"publicationDate":"2025-12-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145804880","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-17DOI: 10.1016/j.yjmcc.2025.12.006
Ming Ding , Li Zheng , Tapan A. Patel , Matthew C. Zimmerman , Kaushik P. Patel , Paul L. Sorgen
Hypoxia induces pathological remodeling in cardiomyocytes, in part by disrupting gap junction communication through Connexin43 (Cx43) phosphorylation and internalization. Here, we identify Proline-rich tyrosine kinase 2 (Pyk2) as a critical mediator of hypoxia- and adrenergic-induced Cx43 remodeling and cardiomyocyte dysfunction. Neonatal rat ventricular myocytes exposed to hypoxia (1 % O₂) for 1 or 24 h exhibited increased expression of hypoxia-inducible factor 1α and activated Pyk2 (pY402 and pY579/580), without changes in the total level of Pyk2. Hypoxia also enhanced Cx43 phosphorylation at Y265, a Pyk2-specific site, and increased expression of GJA1–20 k, an alternatively translated Cx43 isoform that supports Cx43 trafficking and mitochondrial function. Pharmacological Pyk2 inhibition with PF4618433 prevented hypoxia-induced Pyk2 activation, Cx43 phosphorylation, and attenuated the increase in GJA1–20 k expression. Immunofluorescence analysis revealed that hypoxia reduced Cx43 localization at intercellular junctions, an effect reversed by PF4618433 treatment. Functionally, Pyk2 inhibition reduced cell damage, as reflected by lower lactate dehydrogenase release and improved contractile activity. Mechanistically, PF4618433 attenuated apoptosis, oxidative stress, and preserved mitochondrial membrane potential, consistent with improved mitochondrial function. Furthermore, norepinephrine-induced Pyk2 activation and Cx43 Y265 phosphorylation were comparably suppressed by PF4618433, linking Pyk2 to both hypoxic as well as adrenergic stress signaling in cardiomyocytes. These findings demonstrate that Pyk2 activation promotes Cx43 downregulation, contributing to cardiomyocyte injury under hypoxic and adrenergic stress. Inhibition of Pyk2 preserves gap junction integrity, maintains mitochondrial function, and enhances cell survival, supporting Pyk2 as a promising therapeutic target in cardiac injury.
{"title":"Inhibition of Pyk2 prevents Cx43 remodeling and cardiomyocyte injury during hypoxic and adrenergic stress","authors":"Ming Ding , Li Zheng , Tapan A. Patel , Matthew C. Zimmerman , Kaushik P. Patel , Paul L. Sorgen","doi":"10.1016/j.yjmcc.2025.12.006","DOIUrl":"10.1016/j.yjmcc.2025.12.006","url":null,"abstract":"<div><div>Hypoxia induces pathological remodeling in cardiomyocytes, in part by disrupting gap junction communication through Connexin43 (Cx43) phosphorylation and internalization. Here, we identify Proline-rich tyrosine kinase 2 (Pyk2) as a critical mediator of hypoxia- and adrenergic-induced Cx43 remodeling and cardiomyocyte dysfunction. Neonatal rat ventricular myocytes exposed to hypoxia (1 % O₂) for 1 or 24 h exhibited increased expression of hypoxia-inducible factor 1α and activated Pyk2 (pY402 and pY579/580), without changes in the total level of Pyk2. Hypoxia also enhanced Cx43 phosphorylation at Y265, a Pyk2-specific site, and increased expression of GJA1–20 k, an alternatively translated Cx43 isoform that supports Cx43 trafficking and mitochondrial function. Pharmacological Pyk2 inhibition with PF4618433 prevented hypoxia-induced Pyk2 activation, Cx43 phosphorylation, and attenuated the increase in GJA1–20 k expression. Immunofluorescence analysis revealed that hypoxia reduced Cx43 localization at intercellular junctions, an effect reversed by PF4618433 treatment. Functionally, Pyk2 inhibition reduced cell damage, as reflected by lower lactate dehydrogenase release and improved contractile activity. Mechanistically, PF4618433 attenuated apoptosis, oxidative stress, and preserved mitochondrial membrane potential, consistent with improved mitochondrial function. Furthermore, norepinephrine-induced Pyk2 activation and Cx43 Y265 phosphorylation were comparably suppressed by PF4618433, linking Pyk2 to both hypoxic as well as adrenergic stress signaling in cardiomyocytes. These findings demonstrate that Pyk2 activation promotes Cx43 downregulation, contributing to cardiomyocyte injury under hypoxic and adrenergic stress. Inhibition of Pyk2 preserves gap junction integrity, maintains mitochondrial function, and enhances cell survival, supporting Pyk2 as a promising therapeutic target in cardiac injury.</div></div>","PeriodicalId":16402,"journal":{"name":"Journal of molecular and cellular cardiology","volume":"211 ","pages":"Pages 119-130"},"PeriodicalIF":4.7,"publicationDate":"2025-12-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145786581","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-09DOI: 10.1016/j.yjmcc.2025.11.010
Eliza Sassu , Gavin Tumlinson , Dragana Stefanovska , Marbely C. Fernández , Pia Iaconianni , Josef Madl , Tomás A. Brennan , Manuel Koch , Breanne A. Cameron , Sebastian Preissl , Ursula Ravens , Franziska Schneider-Warme , Peter Kohl , Callum M. Zgierski-Johnston , Luis Hortells
{"title":"Corrigendum to “Age-related structural and functional changes of the intracardiac nervous system” Journal of Molecular and Cellular Cardiology, Volume 187 (2024) 1–14]","authors":"Eliza Sassu , Gavin Tumlinson , Dragana Stefanovska , Marbely C. Fernández , Pia Iaconianni , Josef Madl , Tomás A. Brennan , Manuel Koch , Breanne A. Cameron , Sebastian Preissl , Ursula Ravens , Franziska Schneider-Warme , Peter Kohl , Callum M. Zgierski-Johnston , Luis Hortells","doi":"10.1016/j.yjmcc.2025.11.010","DOIUrl":"10.1016/j.yjmcc.2025.11.010","url":null,"abstract":"","PeriodicalId":16402,"journal":{"name":"Journal of molecular and cellular cardiology","volume":"211 ","pages":"Pages 92-93"},"PeriodicalIF":4.7,"publicationDate":"2025-12-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145723911","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-08DOI: 10.1016/j.yjmcc.2025.12.004
Marine Cacheux , Benjamin Strauss , Shestruma Parajuli , Aymen Halouani , Michael G. Katz , Seun Imani , Samar Antar , Nestor Bedoya , Lahouaria Hadri , Fadi G. Akar , Yassine Sassi
Pulmonary Arterial Hypertension (PAH), a major cause of right ventricular failure, is associated with a high 5-year mortality rate. Arrhythmias account for a significant proportion of morbidity and mortality in PAH patients. Hence, there is a critical need for new therapies to effectively treat PAH-related cardiac arrhythmias. The purpose of this study was to evaluate the efficacy of extracellular cyclic adenosine monophosphate (e-cAMP) treatment in reversing pathophysiological electrophysiological (EP) remodeling and arrhythmia propensity caused by PAH. Ex-vivo optical action potential (AP) mapping, real-time reverse transcription–polymerase chain reaction, immunostaining, morphological and histologic analyses were performed on two different models of pulmonary hypertension (Monocrotaline and Sugen/pneumonectomy) to test the impact of e-cAMP treatment in suppressing ventricular arrhythmias in PAH. PAH diseased rats from both models exhibited a high propensity of inducible ventricular tachycardia (VT). Remarkably, e-cAMP treatment suppressed the incidence of VT in both models. Examination of the EP substrate revealed action potential duration prolongation and marked conduction slowing in PAH-diseased animals. These features, however, were significantly reversed by e-cAMP treatment. Moreover, e-cAMP reversed the development of AP alternans in PAH. Extracellular cAMP-treated rats exhibited a significant decrease in myocardial fibrosis and hypertrophic remodeling. Reversal of EP remodeling by e-cAMP was accompanied by decreased pulmonary vascular remodeling and by restored cardiac expression of key ion channel transcripts. Extracellular cAMP treatment reduces the incidence of ventricular arrhythmias and suppresses pathological EP remodeling by restoring cardiac and pulmonary vascular remodeling. This approach may represent a new therapeutic modality for arrhythmia suppression in PAH patients.
{"title":"Extracellular-cAMP suppresses pulmonary arterial hypertension-induced ventricular arrhythmias","authors":"Marine Cacheux , Benjamin Strauss , Shestruma Parajuli , Aymen Halouani , Michael G. Katz , Seun Imani , Samar Antar , Nestor Bedoya , Lahouaria Hadri , Fadi G. Akar , Yassine Sassi","doi":"10.1016/j.yjmcc.2025.12.004","DOIUrl":"10.1016/j.yjmcc.2025.12.004","url":null,"abstract":"<div><div>Pulmonary Arterial Hypertension (PAH), a major cause of right ventricular failure, is associated with a high 5-year mortality rate. Arrhythmias account for a significant proportion of morbidity and mortality in PAH patients. Hence, there is a critical need for new therapies to effectively treat PAH-related cardiac arrhythmias. The purpose of this study was to evaluate the efficacy of extracellular cyclic adenosine monophosphate (e-cAMP) treatment in reversing pathophysiological electrophysiological (EP) remodeling and arrhythmia propensity caused by PAH. Ex-vivo optical action potential (AP) mapping, real-time reverse transcription–polymerase chain reaction, immunostaining, morphological and histologic analyses were performed on two different models of pulmonary hypertension (Monocrotaline and Sugen/pneumonectomy) to test the impact of e-cAMP treatment in suppressing ventricular arrhythmias in PAH. PAH diseased rats from both models exhibited a high propensity of inducible ventricular tachycardia (VT). Remarkably, e-cAMP treatment suppressed the incidence of VT in both models. Examination of the EP substrate revealed action potential duration prolongation and marked conduction slowing in PAH-diseased animals. These features, however, were significantly reversed by e-cAMP treatment. Moreover, e-cAMP reversed the development of AP alternans in PAH. Extracellular cAMP-treated rats exhibited a significant decrease in myocardial fibrosis and hypertrophic remodeling. Reversal of EP remodeling by e-cAMP was accompanied by decreased pulmonary vascular remodeling and by restored cardiac expression of key ion channel transcripts. Extracellular cAMP treatment reduces the incidence of ventricular arrhythmias and suppresses pathological EP remodeling by restoring cardiac and pulmonary vascular remodeling. This approach may represent a new therapeutic modality for arrhythmia suppression in PAH patients.</div></div>","PeriodicalId":16402,"journal":{"name":"Journal of molecular and cellular cardiology","volume":"211 ","pages":"Pages 109-118"},"PeriodicalIF":4.7,"publicationDate":"2025-12-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145723899","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}